{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:48:33Z","timestamp":1769762913493,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.clinthera.2005.06.009","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T18:13:25Z","timestamp":1124820805000},"page":"674-683","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic options for pneumococcal pneumonia in Turkey"],"prefix":"10.1016","volume":"27","author":[{"given":"Serkan","family":"Oncu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaaddin","family":"Pahsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.06.009_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2004.09.008","article-title":"Community-acquired pneumonia in northern Australia: Low mortality in a tropical region using locally-developed treatment guidelines","volume":"9","author":"Elliott","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijantimicag.2004.05.006","article-title":"Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: A 5-year experience","volume":"24","author":"Ioachimescu","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2005.06.009_bib3","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/S0002-9343(99)00099-6","article-title":"Treatment of pneumococcal pneumonia: The case for penicillin G","volume":"107","author":"Bryan","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0025-7125(05)70385-0","article-title":"Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?","volume":"85","author":"Bauer","year":"2001","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2005.06.009_bib5","first-page":"394","article-title":"Pneumococcal bacteraemia in south Auckland: A five year review with emphasis on prescribing practices","volume":"105","author":"Singh","year":"1992","journal-title":"N Z Med J"},{"key":"10.1016\/j.clinthera.2005.06.009_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(67)92346-X","article-title":"A resistant pneumococcus","volume":"290","author":"Hansman","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.06.009_bib7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/174.5.986","article-title":"The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System","volume":"174","author":"Butler","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib8","series-title":"Internal Medicine","first-page":"1868","article-title":"Pneumonia","author":"Neu","year":"1994"},{"key":"10.1016\/j.clinthera.2005.06.009_bib9","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1016\/j.clinthera.2005.06.009_bib10","series-title":"Principles and Practice of Infectious Diseases","first-page":"2392","article-title":"Streptococcus pneumoniae","author":"Musher","year":"2005"},{"key":"10.1016\/j.clinthera.2005.06.009_bib11","first-page":"243","article-title":"Susceptibility patterns of clinical Streptococcus pneumoniae isolates against penicillin and other antibiotics [in Turkish]","volume":"15","author":"Kilic","year":"2001","journal-title":"Infek Derg"},{"key":"10.1016\/j.clinthera.2005.06.009_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000077810","article-title":"Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates","volume":"50","author":"Oncu","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clinthera.2005.06.009_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijantimicag.2003.11.009","article-title":"Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes","volume":"24","author":"Sener","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2005.06.009_bib14","first-page":"46","article-title":"Resistance among invasive pneumococci in Sivas province [in Turkish]","volume":"15","author":"Erdem","year":"2002","journal-title":"Klimik Derg"},{"key":"10.1016\/j.clinthera.2005.06.009_bib15","first-page":"79","article-title":"Invasive Streptococcus pneumoniae infections and antibiotic resistance patterns in children [in Turkish]","volume":"16","author":"Tanir","year":"2003","journal-title":"Klimik Derg"},{"key":"10.1016\/j.clinthera.2005.06.009_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0924-8579(03)00150-X","article-title":"In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis","volume":"22","author":"Kucukbasmaci","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2005.06.009_bib17","first-page":"10","article-title":"Susceptibility pattern of penicillin against Streptococcus pneumoniae isolated from lower respiratory tract infections [in Turkish]","volume":"2","author":"Senol","year":"2001","journal-title":"Toraks Derg"},{"key":"10.1016\/j.clinthera.2005.06.009_bib18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1469-0691.2003.00780.x","article-title":"Antimicrobial resistance patterns of respiratory pathogens: A local report from Turkey","volume":"9","author":"Zarakolu","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2005.06.009_bib19","first-page":"1","article-title":"Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty [in Turkish]","volume":"37","author":"Yenisehirli","year":"2003","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.clinthera.2005.06.009_bib20","first-page":"433","article-title":"Investigation of penicillin susceptibility with E-test against Streptococcus pneumoniae strains isolated from patients at Hacettepe. University Medical Faculty [in Turkish]","volume":"17","author":"Zer","year":"2003","journal-title":"Infeksiyon Dergisi"},{"key":"10.1016\/j.clinthera.2005.06.009_bib21","first-page":"243","article-title":"The epidemiology of penicillin resistance in Streptococcus pneumoniae","volume":"14","author":"Forward","year":"1999","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.clinthera.2005.06.009_bib22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study","volume":"43","author":"Jacobs","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/514783","article-title":"Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study","volume":"28","author":"Song","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.06.009_bib24","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/clinids\/24.Supplement_1.S85","article-title":"Antibiotic resistance in Streptococcus pneumoniae","volume":"24","author":"Tomasz","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.idc.2004.04.005","article-title":"Antimicrobial agents in the treatment of bacterial meningitis","volume":"18","author":"Sinner","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2005.06.009_bib26","first-page":"920","article-title":"Antibiotic-resistant pneumococcal disease in South African children","volume":"146","author":"Friedland","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.clinthera.2005.06.009_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006454-199510000-00013","article-title":"Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease","volume":"14","author":"Friedland","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2005.06.009_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain [published correction appears in N Engl J Med. 1995;333:1655]","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib29","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/516340","article-title":"Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children","volume":"26","author":"Choi","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/peds.103.2.409","article-title":"Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae","volume":"103","author":"Deeks","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2005.06.009_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00006454-200103000-00013","article-title":"Standard case management of pneumonia in hospitalized children in Uruguay, 1997 to 1998","volume":"20","author":"Pirez","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2005.06.009_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0732-8893(97)00020-5","article-title":"Efficacy of beta-lactam antibiotics: Integration of pharmacokinetics and pharmacodynamics","volume":"27","author":"Cars","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2005.06.009_bib34","first-page":"7","article-title":"Choosing an antibiotic on the basis of pharmacodynamics","volume":"77","author":"Craig","year":"1998","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.clinthera.2005.06.009_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00001432-200104000-00010","article-title":"Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections","volume":"14","author":"Andes","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/0003-4819-82-2-189","article-title":"\u201cComparably massive\u201d penicillin G therapy in renal failure","volume":"82","author":"Bryan","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM196609222751203","article-title":"Comparative blood levels of hetacillin, ampicillin and penicillin G","volume":"275","author":"Tuano","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.112.6.1657","article-title":"Penicillin dosing for pneumococcal pneumonia","volume":"112","author":"Bryan","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2005.06.009_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01699983","article-title":"Current usefulness of procaine penicillin in the treatment of pneumococcal pneumonia","volume":"17","author":"Cabellos","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM197101282840403","article-title":"Increased resistance to penicillin of pneumococci isolated from man","volume":"284","author":"Hansman","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(77)92892-6","article-title":"Streptococcus pneumoniae resistant to penicillin and chloramphenicol","volume":"2","author":"Appelbaum","year":"1977","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2005.06.009_bib43","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/314057","article-title":"Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae","volume":"31","author":"Appelbaum","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.06.009_bib44","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S1201-9712(03)90067-1","article-title":"Achieving bacterial eradication using pharmacokinetic\/pharmacodynamic principles","volume":"7","author":"Dagan","year":"2003","journal-title":"Int J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2005.06.009_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1470-9465.2004.00865.x","article-title":"Proof of concept: Performance testing in models","volume":"10","author":"Craig","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2005.06.009_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/AAC.43.1.35","article-title":"Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae","volume":"43","author":"Woodnutt","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib47","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/jac\/dkg458","article-title":"Oral pharmacokinetically enhanced co-amoxiclav 2000\/125 mg, twice daily, compared with co-amoxiclav 875\/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults","volume":"52","author":"Garau","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0163-4453(87)92127-X","article-title":"Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus","volume":"14","author":"Sacho","year":"1987","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2005.06.009_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-3476(98)70510-4","article-title":"Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia","volume":"132","author":"Buckingham","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2005.06.009_bib50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/588389","article-title":"Failure of treatment of pneumonia associated with highly resistant pneumococci in a child","volume":"29","author":"Dowell","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0732-8893(95)00053-D","article-title":"Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins","volume":"22","author":"Craig","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib52","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jac\/45.5.623","article-title":"Streptococcus pneumoniae in the USA: In vitro susceptibility and pharmacodynamic analysis","volume":"45","author":"Mason","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib53","series-title":"Principles and Practice of Infectious Diseases","first-page":"611","article-title":"Antimicrobial management: Cost and resistance","author":"Polk","year":"2005"},{"key":"10.1016\/j.clinthera.2005.06.009_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/13543784.11.4.529","article-title":"Recent developments in carbapenems","volume":"11","author":"Bonfiglio","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.clinthera.2005.06.009_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0025-7125(16)30037-2","article-title":"Carbapenems","volume":"79","author":"Norrby","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2005.06.009_bib56","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.43.10.2510","article-title":"Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates","volume":"43","author":"Oster","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996\u20131997) multicenter surveillance study","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s100960050337","article-title":"Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens","volume":"18","author":"Cizman","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1378\/chest.116.2.535","article-title":"The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: Are we looking in the wrong place?","volume":"116","author":"Siegel","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2005.06.009_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0149-2918(00)87973-4","article-title":"Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance","volume":"22","author":"Gotfried","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2005.06.009_bib61","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib62","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","article-title":"Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams","volume":"51","author":"Van Kerkhoven","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib64","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0732-8893(02)00379-6","article-title":"Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation","volume":"43","author":"Kays","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib66","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib67","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.118.6.1839-a","article-title":"Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy","volume":"118","author":"Waterer","year":"2000","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.06.009_bib68","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia","volume":"34","author":"Lynch","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib69","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994\u20131995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib70","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/45.3.401","article-title":"Pneumococcal macrolide resistance-not a myth","volume":"45","author":"Perez-Trallero","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib72","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.42.9.2425","article-title":"Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae","volume":"42","author":"Johnston","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijid.2004.03.008","article-title":"PROTEKT 1999\u20132000: A multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan","volume":"9","author":"Inoue","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib74","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ijantimicag.2004.06.018","article-title":"Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections","volume":"24","author":"Ortega","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2005.06.009_bib75","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1128\/AAC.44.12.3395-3401.2000","article-title":"Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America","volume":"44","author":"Tait-Kamradt","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib76","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/AAC.48.9.3305-3311.2004","article-title":"In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002","volume":"48","author":"Powis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib77","first-page":"10","article-title":"Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan","volume":"83","author":"Rasmussen","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.clinthera.2005.06.009_bib78","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(97)10294-X","article-title":"Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: Randomised controlled trial","volume":"352","author":"Straus","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.06.009_bib79","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bmj.292.6522.730","article-title":"Meningitis and pneumonia due to novel multiply resistant pneumococci","volume":"292","author":"Klugman","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.clinthera.2005.06.009_bib80","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","article-title":"Doxycycline revisited","volume":"157","author":"Joshi","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2005.06.009_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/joc.2005.17.1.25","article-title":"Antibiotic resistance in pathogenic Streptococcus pneumoniae isolates in Turkey","volume":"17","author":"Erdem","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/bies.950180810","article-title":"Molecular mechanisms of drug inhibition of DNA gyrase","volume":"18","author":"Lewis","year":"1996","journal-title":"Bioessays"},{"key":"10.1016\/j.clinthera.2005.06.009_bib83","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0891-5520(05)70260-9","article-title":"Fluoroquinolones","volume":"14","author":"O'Donnell","year":"2000","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2005.06.009_bib84","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1128\/AAC.38.12.2730","article-title":"Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar","volume":"38","author":"Hyatt","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib85","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/BF01967510","article-title":"Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin","volume":"9","author":"Perez-Trallero","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2005.06.009_bib86","series-title":"The Quinolones","first-page":"229","article-title":"Treatment of respiratory infections with quinolones","author":"Niederman","year":"1998"},{"key":"10.1016\/j.clinthera.2005.06.009_bib87","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0924-8579(00)00252-1","article-title":"The role of fluoroquinolones in respiratory tract infections: Community acquired pneumonia","volume":"16","author":"Garcia-Rodriguez","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2005.06.009_bib88","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.43.8.2000","article-title":"Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones","volume":"43","author":"Pestova","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib89","series-title":"The Quinolones","first-page":"1","article-title":"The quinolones: History and overview","author":"Ball","year":"1998"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.06.009_bib90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/45.suppl_3.101","article-title":"Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones","volume":"45","author":"Morrissey","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2005.06.009_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199958002-00003","article-title":"Mechanisms of fluoroquinolone resistance: An update 1994\u20131998","volume":"58","author":"Piddock","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2005.06.009_bib92","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jac\/dkg469","article-title":"Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England","volume":"52","author":"Johnson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2005.06.009_bib93","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.46.3.680-688.2002","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994\u20131995","volume":"46","author":"Brueggemann","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T23:12:05Z","timestamp":1552864325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0149291805001025"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.06.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}